Priming the Liver to Resist Metastasis of Colorectal Cancer

来源 :2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会 | 被引量 : 0次 | 上传用户:Johnson_Gu
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Currently there are no approved treatments to reduce the occurrence of colorectal liver metastasis.In this report, we formulate a galactose-PEG lipid calcium phosphate (LCP) nanoparticle to deliver plasmid DNA (pDNA) to the liver (hepatocytes) in order to express an engineered CXCL12-trap protein.
其他文献
会议
会议
会议
  Oral administration of drugs is the most common and convenient method.However, the oral bioavailability of hydrophilic macromolecules and peptide and protei
会议
  Protecting proteins from aggregation and maintaining their biological activities is one of the most important issues in both protein science and protein eng
会议
  In vivo application of drug delivery systems faces inevitable challenges of numerous physiological barriers.Overcoming of these barriers often requires very
会议
  Lung metastasis is the leading cause of cancer-related death and is highly resistant to conventional therapies.Suicide gene therapy has been identified as a
会议
会议
恶性肿瘤是严重危害我国人民生命健康的重大疾病,面对肿瘤发病率和死亡率的不断上升,如何缓解和有效治疗肿瘤已成为我国迫切需要解决的重大科学问题.近年来我国乳腺癌发病率
会议
  In this lecture, we shall present our recent study focusing on a compound transdermal patch containing Teriflunomide(TEF) and lornoxicam (LOX), which is des